
St George Mining is a pre-revenue critical-minerals explorer advancing its 100%-owned Araxá rare earths-niobium project in Brazil. Resource growth, funding, studies and potential partnerships offer upside, while dilution, execution and commodity-price risks remain material
.webp&w=828&q=75)
Wildcat Resources (ASX: WC8) advances its Pilbara lithium portfolio with expanding high-grade discoveries, a progressing DFS at Tabba Tabba, and strong cash reserves, positioning the company for transformational growth amid rising global lithium demand.

We view Invictus Energy as a rare example of an explorer with a clear pathway to development in one of Africa’s last underexplored rift systems. The Mukuyu gas-condensate discovery in Zimbabwe’s Cabora Bassa Basin anchors the portfolio, while high-impact follow-up at Musuma-1 and a strategic financing partnership with Al Mansour Holdings (AMH) materially de-risk the next stage of value creation.

EchoIQ is expanding its US presence through new funding, partnerships, clinical research, and hospital deployments. Its AI-based cardiac software continues to gain commercial traction, while the chart shows a pullback to key support within a longer-term rising trend.

Lumos Diagnostics continues to expand its commercial footprint through FDA clearance, growing U.S. adoption, manufacturing partnerships, and paediatric research. The company now focuses on turning regulatory success and market access into recurring sales, broader reimbursement, and sustainable long-term growth.

Invictus Energy is progressing its Cabora Bassa gas project in Zimbabwe, with Mukuyu appraisal and Musuma-1 drilling as key catalysts. While the PPSA reduces regulatory risk, IVZ remains a volatile, pre-revenue explorer reliant on external funding.